NovaSure impedance controlled endometrial ablation: long-term follow-up results.

[1]  A. Antsaklis,et al.  The effect of hysterectomy on sexuality and psychological changes , 2006, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[2]  M. Hickey,et al.  Endometrial destruction techniques for heavy menstrual bleeding. , 2005, The Cochrane database of systematic reviews.

[3]  A. Gallinat.  NovaSure impedance controlled system for endometrial ablation: three-year follow-up on 107 patients. , 2004, American journal of obstetrics and gynecology.

[4]  B. Mol,et al.  Randomised controlled trial of bipolar radio‐frequency endometrial ablation and balloon endometrial ablation , 2004, BJOG : an international journal of obstetrics and gynaecology.

[5]  Jay Cooper,et al.  Summary of safety and effectiveness data from FDA: a valuable source of information on the performance of global endometrial ablation devices. , 2004, The Journal of reproductive medicine.

[6]  A. Stewart,et al.  Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial. , 2004, JAMA.

[7]  R. Garry,et al.  A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding. , 2003, Fertility and sterility.

[8]  R. Sabbah,et al.  Assessment and comparison of intraoperative and postoperative pain associated with NovaSure and ThermaChoice endometrial ablation systems. , 2003, The Journal of the American Association of Gynecologic Laparoscopists.

[9]  P. Jacobs,et al.  Use of health services associated with increased menstrual loss in the United States. , 2003, American journal of obstetrics and gynecology.

[10]  O. Istre,et al.  Endometrial ablation with NovaSure™ GEA, a pilot study , 2003, Acta obstetricia et gynecologica Scandinavica.

[11]  J. Cooper,et al.  A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia. , 2002, The Journal of the American Association of Gynecologic Laparoscopists.

[12]  P. Jacobs,et al.  Work Loss Associated With Increased Menstrual Loss in the United States , 2002, Obstetrics and gynecology.

[13]  A. Gallinat,et al.  NovaSure impedance-controlled system for endometrial ablation. , 2002, The Journal of the American Association of Gynecologic Laparoscopists.

[14]  T. Fulop,et al.  Is endometrial pretreatment necessary in NovaSure™ 3‐D endometrial ablation? , 2001 .

[15]  R. Neuwirth.  Hysteroscopy and gynecology: past, present, and future. , 2001, The Journal of the American Association of Gynecologic Laparoscopists.

[16]  A. Sinha.  A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years , 1999, British journal of obstetrics and gynaecology.

[17]  A. Magos,et al.  Endometrial resection for the treatment of menorrhagia. , 1996, The New England journal of medicine.

[18]  M. Sculpher,et al.  An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia , 1993 .

[19]  J. Higham,et al.  Assessment of menstrual blood loss using a pictorial chart , 1990, British journal of obstetrics and gynaecology.

[20]  H. Ory,et al.  Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. The Collaborative Review of Sterilization. , 1982, American journal of obstetrics and gynecology.

[21]  A. Stewart,et al.  Effect of hysterectomy versus medical treatment on health-related quality of life and sexual functioning , 2004 .